Xspray Pharma

Xspray Pharma, Sprycel, patent, lawsuit, Sprycel generic, chronic myeloid leukemia, acute lymphatic leukemia, Bristol Myers Squibb

Xspray Pharma settles with BMS over Sprycel generic, awaits FDA nod

Anika Sharma

Xspray Pharma, which encountered an FDA setback in July, was initially aiming to launch its competitor to Bristol Myers Squibb’s ...